NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

膿毒症診斷分析、原因、產品、實驗室、位置、COVID-19 相關市場分析和預測的全球市場:2020-2025

SEPSIS DIAGNOSTICS. Global Markets by Assay, by Cause, by Product, by Lab, and by Place. With Executive and Consultant Guides and COVID-19 Related Sepsis Market Analysis and Forecasts 2020 - 2025

出版商 Howe Sound Research 商品編碼 1005156
出版日期 內容資訊 英文 366 Pages
商品交期: 最快1-2個工作天內
價格
膿毒症診斷分析、原因、產品、實驗室、位置、COVID-19 相關市場分析和預測的全球市場:2020-2025 SEPSIS DIAGNOSTICS. Global Markets by Assay, by Cause, by Product, by Lab, and by Place. With Executive and Consultant Guides and COVID-19 Related Sepsis Market Analysis and Forecasts 2020 - 2025
出版日期: 2021年05月11日內容資訊: 英文 366 Pages
簡介

敗血症每年導致超過 4500 萬人在沒有明確診斷的情況下死亡。現在,COVID 大流行正在增加敗血症導致的死亡人數。

本報告調查和分析了全球膿毒症診斷市場,並提供了有關市場規模預測、挑戰、前景、關鍵趨勢和截至 2025 年的新機遇的系統信息。

目錄

第 1 章市場指南

第二章介紹和市場定義

  • 膿毒症診斷概述
  • 市場定義
  • 調查方法
  • 美國醫療市場和實驗室檢測:展望

第 3 章敗血症:當前科學

  • 什麼是敗血症?
    • 器官損傷
    • 新生兒敗血症
    • 預後
  • 診斷
    • 感染的識別
    • 生物標誌物
    • 鑑別診斷
    • 細胞因子風暴:需要診斷
  • 敗血症的原因
    • 敗血症的進展
    • 細胞因子風暴:COVID 和其他情況
  • 流行率
    • COVID 對敗血症患病率的影響

第四章行業概況

  • 動態市場公司
    • 學術研究實驗室
    • 診斷測試開發人員
    • 醫藥/試劑供應商
    • 獨立檢驗實驗室
    • 國家/地區實驗室
    • 醫院實驗室
    • 博士實驗室
    • 審計機構
    • 認證機構

第 5 章市場趨勢

  • 生長促進劑
  • 生長抑製劑
  • 診斷技術的發展

第 6 章膿毒症的診斷:最新進展

  • 近期發展:重要性
  • SpeeDx:呼吸道病毒宿主反應測試的開發
  • Scanogen:使用敗血症應用開發血液感染測試
  • Inflammatix:進入 COVID 檢驗市場
  • Immunexpress:針對冠狀病毒患者分類的敗血症測試的開發
  • 使用便攜式設備更快地診斷敗血症
  • Ontera 和 QuantuMDx 合作的敗血症診斷
  • 通過血液檢測準確預測敗血症的嚴重程度
  • 使用多標誌物等進行形態學發育膿毒症測試。

第七章主要公司簡介

  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Biocartis
  • bioMérieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Bruker
  • Cube Dx
  • Curetis N.V./Curetis GmbH
  • Cytovale
  • DNAe
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • LightDeck Diagnostics
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc

第 8 章全球膿毒症診斷市場概述

  • 膿毒症診斷 - 全球市場概覽:按國家/地區
  • 全球膿毒症診斷市場概覽:按檢測分類
  • 全球膿毒症診斷市場概覽:按原因分類
  • 全球膿毒症診斷市場概覽:按產品分類
  • 全球膿毒症診斷市場概覽:按實驗室
  • 全球膿毒症診斷市場概覽:按地區

第 9 章膿毒症診斷市場:通過檢測

  • 膿毒症診斷:微生物
  • 膿毒症診斷:PCR
  • 膿毒症診斷:免疫測定
  • 膿毒症診斷:其他傳染病
  • 膿毒症診斷:Biomarker MDx
  • 膿毒症診斷:其他生物標誌物

第 10 章全球膿毒症診斷市場:按原因

  • 膿毒症診斷:胃腸道
  • 膿毒症診斷:呼吸系統 (COVID-19)
  • 膿毒症診斷:呼吸系統(其他)
  • 敗血症診斷:新生兒
  • 膿毒症診斷:其他

第 11 章全球膿毒症診斷市場:按產品

  • 膿毒症診斷:儀器
  • 膿毒症診斷:消耗品
  • 膿毒症診斷:軟件服務

第 12 章全球膿毒症診斷市場:按實驗室

  • 膿毒症診斷:在實驗室
  • 膿毒症診斷:護理點

第 13 章全球膿毒症診斷市場:按位置

  • 膿毒症診斷:醫院
  • 膿毒症診斷:其他

第 14 章附錄

  • 美國醫療保險系統:2021 年實驗室費用表
目錄

OVERVIEW:

Sepsis is killing over 45 million people a year with no definitive diagnostic in hand. And now the COVID Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life saving diagnostics can command a premium in the market, especially deaths related to COVID infections. Understand the different drivers of this huge global diagnostic market and where the opportunity lies.

Our facts and support = Your success.

The report forecasts the market size out to 2025. Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnositic and the Genomics Revolution are merging to create new diagnostic opportunities.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis - COVID & Sepsis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 An Overview of Sepsis Diagnostics
    • 2.1.1 Sepsis the medical emergency
    • 2.1.2 Sepsis Diagnosis and Comorbidity
  • 2.2 Market Definition
    • 2.2.1 Market Size
    • 2.2.2 Currency
    • 2.2.3 Years
    • 2.2.4 Microbiology
    • 2.2.5 PCR
    • 2.2.6 Immunoassay
    • 2.2.7 Other Infectious Disease
    • 2.2.8 Syndromic PoC
    • 2.2.9 Biomarkers Molecular Diagnostics
    • 2.2.10 Biomarkers Other
    • 2.2.11 Limitations
  • 2.3 Methodology
    • 2.3.1 Authors
    • 2.3.2 Sources
  • 2.4 U.S. Medical Market and laboratory Testing - Perspective
    • 2.4.1 U.S. Medicare Expenditures for Laboratory Testing

3 Sepsis - Current Science

  • 3.1 What is Sepsis?
    • 3.1.1 Organ Damage
    • 3.1.2 Neonatal sepsis
    • 3.1.3 Prognosis
  • 3.2 Diagnosis
    • 3.2.1 Infection Identification
    • 3.2.2 Biomarkers
    • 3.2.3 Differential diagnosis
    • 3.2.4 The Cytokine Storm - Diagnostic Needs
  • 3.3 Causes of Sepsis
    • 3.3.1 Sepsis Progression
    • 3.3.2 The Cytokine Storm - COVID and Other Situations
  • 3.4 Prevalence
    • 3.4.1 Impact of COVID on Sepsis Prevalence

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Pharmaceutical/Reagent Supplier
    • 4.1.4 Independent Testing Lab
    • 4.1.5 Public National/regional lab
    • 4.1.6 Hospital lab
    • 4.1.7 Physician Lab
    • 4.1.8 Audit Body
    • 4.1.9 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 Increasing Prevalence
    • 5.1.2 Antimicrobial Resistance
    • 5.1.3 Increasing Diagnosis
    • 5.1.4 Multiplex Diagnostics Impacts
    • 5.1.5 The Aging World
    • 5.1.6 COVID Market Impact
  • 5.2 Factors Limiting Growth
    • 5.2.1 The Cost Curve Shrinks the Market
    • 5.2.2 The Diagnostics Dillemma
    • 5.2.3 Adoption Lag and Cost Control
  • 5.3 Diagnostic Technology Development
    • 5.3.1 The Multiplex Opportunity
    • 5.3.2 Shifting Role of Physicians in Diagnosis
    • 5.3.3 Diagnostics Moves Out of the Lab
    • 5.3.4 Biomarkers and Algorithms
    • 5.3.5 Rapid Testing Changing Medical Practice
    • 5.3.6 Genome Role and Big Data
    • 5.3.7 The Next Five Years

6 Sepsis Diagnostics - Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Study Establishes Cytovale IntelliSep Test for Rapid Diagnosis of Sepsis
  • 6.3 Baebies Awarded $11.6M to Develop Diagnostic Platform to ID Sepsis
  • 6.4 Personalized Medicine in Sepsis
  • 6.5 Point-of-care Device can Diagnose Sepsis in 30 Minutes
  • 6.6 SpeeDx Developing Respiratory Virus Host-Response Test
  • 6.7 Scanogen Developing Blood Infection Test with Sepsis Application
  • 6.8 Inflammatix Moving Into COVID Test Market and Developing New Sepsis Dx
  • 6.9 Immunexpress, Biocartis to Roll Out Sepsis Test
  • 6.10 Sepset Biosciences Using COVID-19 Patient Samples to Validate Sepsis Test
  • 6.11 Immunexpress to Develop Sepsis Test for Coronavirus Patient Triage
  • 6.12 DNAe Developing POC Sequencing Platform for Coronavirus, Sepsis
  • 6.13 NGS technique offers quick, accurate diagnosis of Sepsis
  • 6.14 Portable device diagnoses sepsis faster
  • 6.15 Ontera and QuantuMDx Collaborate to Advance Sepsis Diagnosis
  • 6.16 Blood Test Accurately Predicts Sepsis Severity
  • 6.17 Sepsis diagnostics: HHS to advance development of Cytovale rapid test
  • 6.18 Mologic Developing Sepsis Test Using Multimarker
  • 6.19 Abionic: Study Demonstrates Diagnosis of Sepsis in 5 Minutes
  • 6.20 T2 Biosystems Introduces New Data and Updates for Rapid Diagnostic Technology
  • 6.21 Sepsis found to fit into 4 Subtypes
  • 6.22 GenMark Diagnostics Receives FDA Clearance for Blood Panel
  • 6.23 Novacyt, Immunexpress Extend Sepsis Assay Development Partnership
  • 6.24 New Test Could Diagnose Sepsis Faster
  • 6.25 Immunexpress Wins $745K HHS Contract for Rapid Sepsis Assay
  • 6.26 Curetis' Unyvero Application Cartridges Receive Regulatory Approvals
  • 6.27 Luminex Buys MilliporeSigma's Flow Cytometry Portfolio
  • 6.28 Experimental 2.5-minute Sepsis Test Discovered
  • 6.29 sphingotec raises €20 million
  • 6.30 SeLux Diagnostics Announces Sepsi U.S. HHS/BARDA Research Funding
  • 6.31 Roche PCT assay cleared as tool in fight against Sepsis
  • 6.32 GeneFluidics selected as finalist for AMR Challenge
  • 6.33 BioDirection, Inc. Announces System to Diagnose and Monitor Sepsis
  • 6.34 sphingotec Adding Advanced POC Testing Platform
  • 6.35 Rapid Detection Using DNAe's LiDia® Bloodstream Infection Technology
  • 6.36 Septec Team Working on 15 Minute Sepsis Diagnosis
  • 6.37 Abionic Announces Rapid Sepsis PoC Diagnostic

7 Profiles of Key Companies

  • 7.1 Abbott Diagnostics
  • 7.2 Abionic
  • 7.3 Accel Diagnostics
  • 7.4 Accelerate Diagnostics
  • 7.5 Axis-Shield Diagnostics Ltd
  • 7.6 Beckman Coulter Diagnostics
  • 7.7 Becton, Dickinson and Company
  • 7.8 Biocartis
  • 7.9 bioMérieux Diagnostics
  • 7.10 Bio-Rad Laboratories, Inc.
  • 7.11 Bruker
  • 7.12 Cube Dx
  • 7.13 Curetis N.V. / Curetis GmbH
  • 7.14 Cytovale
  • 7.15 DNAe
  • 7.16 EKF Diagnostics Holdings
  • 7.17 GeneFluidics
  • 7.18 GenMark Dx
  • 7.19 Grifols
  • 7.20 Immunexpress
  • 7.21 Inflammatix
  • 7.22 LightDeck Diagnostics
  • 7.23 Linear Diagnostics
  • 7.24 Luminex Corp
  • 7.25 Mbio Diagnostics
  • 7.26 Mobidiag
  • 7.27 Nanomix
  • 7.28 Qiagen Gmbh
  • 7.29 Response Biomedical
  • 7.30 Roche Molecular Diagnostics
  • 7.31 SeLux Diagnostics
  • 7.32 Septec
  • 7.33 Siemens Healthineers
  • 7.34 Sphingotec
  • 7.35 T2 Biosystems
  • 7.36 Thermo Fisher Scientific Inc

8 Sepsis Global Diagnostic Markets Overview

  • 8.1 Sepsis Diagnostics - Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Sepsis Diagnostics Markets Overview by Assay
    • 8.2.1 Table - Global Market by Assay
    • 8.2.2 Chart - Global Market by Assay - Segments Growth
    • 8.2.3 Chart - Global Market by Assay - Share by Year
    • 8.2.4 Chart - Global Market by Assay
    • 8.2.5 Chart - Global Market by Assay - Base Year
    • 8.2.6 Chart - Global Market by Assay - Final Year
  • 8.3 Global Sepsis Diagnostics Markets Overview by Cause
    • 8.3.1 Table - Global Market by Cause
    • 8.3.2 Chart - Global Market by Cause - Segments Growth
    • 8.3.3 Chart - Global Market by Cause - Share by Year
    • 8.3.4 Chart - Global Market by Cause
    • 8.3.5 Chart - Global Market by Cause - Base Year
    • 8.3.6 Chart - Global Market by Cause - Final Year
  • 8.4 Global Sepsis Diagnostics Markets Overview by Product
    • 8.4.1 Table - Global Market by Product
    • 8.4.2 Chart - Global Market by Product - Segments Growth
    • 8.4.3 Chart - Global Market by Product - Share by Year
    • 8.4.4 Chart - Global Market by Product
    • 8.4.5 Chart - Global Market by Product - Base Year
    • 8.4.6 Chart - Global Market by Product - Final Year
  • 8.5 Global Sepsis Diagnostics Markets Overview by Lab
    • 8.5.1 Table - Global Market by Lab
    • 8.5.2 Chart - Global Market by Lab - Segments Growth
    • 8.5.3 Chart - Global Market by Lab - Share by Year
    • 8.5.4 Chart - Global Market by Lab
    • 8.5.5 Chart - Global Market by Lab - Base Year
    • 8.5.6 Chart - Global Market by Lab - Final Year
  • 8.6 Global Sepsis Diagnostics Markets Overview by Place
    • 8.6.1 Table - Global Market by Place
    • 8.6.2 Chart - Global Market by Place - Segments Growth
    • 8.6.3 Chart - Global Market by Place - Share by Year
    • 8.6.4 Chart - Global Market by Place
    • 8.6.5 Chart - Global Market by Place - Base Year
    • 8.6.6 Chart - Global Market by Place - Final Year

9 Sepsis Diagnostic Market - by Assay

  • 9.1 Sepsis Diagnostic - Microbiology
    • 9.1.1 Table Sepsis Diagnostic Microbiology - by Country
    • 9.1.2 Chart - Sepsis Diagnostic Microbiology Growth
  • 9.2 Sepsis Diagnostic - PCR
    • 9.2.1 Table Sepsis Diagnostic PCR - by Country
    • 9.2.2 Chart - Sepsis Diagnostic PCR Growth
  • 9.3 Sepsis Diagnostic - Immunoassay
    • 9.3.1 Table Sepsis Diagnostic Immunoassay - by Country
    • 9.3.2 Chart - Sepsis Diagnostic - Immunoassay Growth
  • 9.4 Sepsis Diagnostic - Infectious Disease Other
    • 9.4.1 Table Sepsis Diagnostic Infectious Disease Other - by Country
    • 9.4.2 Chart - Sepsis Diagnostic - Infectious Disease Other Growth
  • 9.5 Sepsis Diagnostic - Biomarker MDx
    • 9.5.1 Table Sepsis Diagnostic Biomarker MDx - by Country
    • 9.5.2 Chart - Sepsis Diagnostic - Biomarker MDx Growth
  • 9.6 Sepsis Diagnostic - Biomarker Other
    • 9.6.1 Table Sepsis Diagnostic Biomarker Other - by Country
    • 9.6.2 Chart - Sepsis Diagnostic - Biomarker Other Growth

10 Global Sepsis Diagnostics Markets - By Cause

  • 10.1 Sepsis Diagnostic - GastroIntestinal
    • 10.1.1 Table Sepsis Diagnostic GastroIntestinal - by Country
    • 10.1.2 Chart - Sepsis Diagnostic GastroIntestinal Growth
  • 10.2 Sepsis Diagnostic - Respiratory COVID-19
    • 10.2.1 Table Sepsis Diagnostic Respiratory COVID-19- by Country
    • 10.2.2 Chart - Sepsis Diagnostic Respiratory COVID-19
  • 10.3 Sepsis Diagnostic - Respiratory Other
    • 10.3.1 Table Sepsis Diagnostic Respiratory Other - by Country
    • 10.3.2 Chart - Sepsis Diagnostic - Respiratory Other Growth
  • 10.4 Sepsis Diagnostic - Neonatal
    • 10.4.1 Table Sepsis Diagnostic Neonatal - by Country
    • 10.4.2 Chart - Sepsis Diagnostic - Neonatal Growth
  • 10.5 Sepsis Diagnostic - Other Cause
    • 10.5.1 Table Sepsis Diagnostic Other Cause - by Country
    • 10.5.2 Chart - Sepsis Diagnostic - Other Cause Growth

11 Global Sepsis Diagnostics Markets - By Product

  • 11.1 Sepsis Diagnostic - Instrumentation
    • 11.1.1 Table Sepsis Diagnostic Instrumentation - by Country
    • 11.1.2 Chart - Sepsis Diagnostic Instrumentation Growth
  • 11.2 Sepsis Diagnostic - Consumables
    • 11.2.1 Table Sepsis Diagnostic Consumables - by Country
    • 11.2.2 Chart - Sepsis Diagnostic Consumables
  • 11.3 Sepsis Diagnostic - Software & Service
    • 11.3.1 Table Sepsis Diagnostic Software & Service - by Country
    • 11.3.2 Chart - Sepsis Diagnostic - Software & Service Growth

12 Global Sepsis Diagnostics Markets - By Lab

  • 12.1 Sepsis Diagnostic - In Lab
    • 12.1.1 Table Sepsis Diagnostic In Lab - by Country
    • 12.1.2 Chart - Sepsis Diagnostic In Lab Growth
  • 12.2 Sepsis Diagnostic - Point of Care
    • 12.2.1 Table Sepsis Diagnostic Point of Care - by Country
    • 12.2.2 Chart - Sepsis Diagnostic Point of Care

13 Global Sepsis Diagnostics Markets - By Place

  • 13.1 Sepsis Diagnostic - Hospital
    • 13.1.1 Table Sepsis Diagnostic Hospital - by Country
    • 13.1.2 Chart - Sepsis Diagnostic Hospital Growth
  • 13.2 Sepsis Diagnostic - Other Place
    • 13.2.1 Table Sepsis Diagnostic Other Place - by Country
    • 13.2.2 Chart - Sepsis Diagnostic Other Place

14 Appendices

  • 14.1 United States Medicare System: 2021 Clinical Laboratory Fees Schedule

Table of Tables

  • Table 1 Lab Spending 2014 to 2024
  • Table 2 sepsis biomarkers - Established and potential
  • Table 3 Market Players by Type
  • Table 4 Five Factors Driving Growth
  • Table 5 Three Factors Limiting Growth
  • Table 6 - Global Sepsis Diagnostics Market by Country/Region
  • Table 7 Global Market by Assay
  • Table 8 Global Market by Cause
  • Table 9 Global Market by Product
  • Table 10 Global Market by Lab
  • Table 11 Global Market by Place
  • Table 12 Sepsis Diagnostic Microbiology by Country
  • Table 13 Sepsis Diagnostic PCR by Country
  • Table 14 Sepsis Diagnostic Immunoassay by Country
  • Table 15 Sepsis Diagnostic Infectious Disease Other by Country
  • Table 16 Sepsis Diagnostic Biomarker MDx by Country
  • Table 17 Sepsis Diagnostic Biomarker Other by Country
  • Table 18 Sepsis Diagnostic GastroIntestinal by Country
  • Table 19 Sepsis Diagnostic Respiratory COVID-19 by Country
  • Table 20 Sepsis Diagnostic Respiratory Other by Country
  • Table 21 Sepsis Diagnostic Neonatal by Country
  • Table 22 Sepsis Diagnostic Other Cause by Country
  • Table 27 Sepsis Diagnostic Instrumentation by Country
  • Table 28 Sepsis Diagnostic Consumables by Country
  • Table 29 Sepsis Diagnostic Software & Service by Country
  • Table 30 Sepsis Diagnostic In Lab by Country
  • Table 31 Sepsis Diagnostic Point of Care by Country
  • Table 32 Sepsis Diagnostic Hospital by Country
  • Table 33 Sepsis Diagnostic Other Place by Country
  • Table 34 2021 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Sepsis Survival graph
  • Figure 2 Percentage of Sepsis Patients with Comorbidity
  • Figure 3 Clinical Lab Spending 2014 to 2024
  • Figure 4 Sepsis Clinical Progression
  • Figure 5 Deaths From Drug Resistant Infections 2050
  • Figure 6 Aggregate Age of World Population
  • Figure 7 Growth in Health Care Spending Developing World
  • Figure 8 Comparing The New Diagnostics and Traditional Testing
  • Figure 9 Growth rates of Sepsis Diagnostics
  • Figure 10 Global Market Share Chart
  • Figure 11 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 12 Sepsis Diagnostics Market by Assay Base Year
  • Figure 13 Sepsis Diagnostics Market by Assay Final Year
  • Figure 14 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 15 Sepsis Diagnostics Market by Cause Base Year
  • Figure 16 Sepsis Diagnostics Market by Cause Final Year
  • Figure 17 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 18 Sepsis Diagnostics Market by Product Base Year
  • Figure 19 Sepsis Diagnostics Market by Product Final Year
  • Figure 20 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 21 Sepsis Diagnostics Market by Lab Base Year
  • Figure 22 Sepsis Diagnostics Market by Lab Final Year
  • Figure 23 Sepsis Diagnostics Market Segment Shift Base vs Final year
  • Figure 24 Sepsis Diagnostics Market by Place Base Year
  • Figure 25 Sepsis Diagnostics Market by Place Final Year
  • Figure 26 Sepsis Diagnostic Microbiology Growth
  • Figure 27 SEPSIS Diagnostics Syndromic POC Panel Growth
  • Figure 28 Sepsis Diagnostic Immunoassay Growth
  • Figure 29 Sepsis Diagnostic Infectious Disease Other Growth
  • Figure 30 Sepsis Diagnostic Biomarker MDx Growth
  • Figure 31 Sepsis Diagnostic Biomarker Other Growth
  • Figure 32 Sepsis Diagnostic GastroIntestinal Growth
  • Figure 33 SEPSIS Diagnostics Respiratory COVID-19
  • Figure 34 Sepsis Diagnostic Respiratory Other Growth
  • Figure 35 Sepsis Diagnostic Neonatal Growth
  • Figure 36 Sepsis Diagnostic Other Cause Growth
  • Figure 41 Sepsis Diagnostic Instrumentation Growth
  • Figure 42 SEPSIS Diagnostics Consumables
  • Figure 43 Sepsis Diagnostic Software & Service Growth
  • Figure 44 Sepsis Diagnostic In Lab Growth
  • Figure 45 SEPSIS Diagnostics Point of Care
  • Figure 46 Sepsis Diagnostic GastroIntestinal Growth
  • Figure 47 SEPSIS Diagnostics Other Place